Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VIATRIS 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VIATRIS 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Viatris Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6ba46877b6397ccd
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VIATRIS 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85026
Holder Company Name: Viatris Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path: /organization/viatris-pharma-limited
Authorization Date: 2020-08-11
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/10 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Viatris Limited
Company Detail Path: /organization/viatris-pharma-limited

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

13,9 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 11, 2020

Approval ID

6ba46877b6397ccd

Type

Standard